abstract |
THE PRESENT INVENTION RELATES TO A COMBINATION, ESPECIALLY A PHARMACEUTICAL COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS (I) AN AT 1-RECEPTOR ANTAGONIST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; (II) (A) AN INSULIN SECRETION ENHANCER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF OR (B) AN INSULIN SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; AND, IN CASE OF A PHARMACEUTICAL COMPOSITION, A PHARMACEUTICALLYACCEPTABLE CARRIER. |